PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.08 and traded as high as $0.09. PURE Bioscience shares last traded at $0.09, with a volume of 35,303 shares trading hands.
PURE Bioscience Price Performance
The firm has a market cap of $9.82 million, a P/E ratio of -1.46 and a beta of 0.06. The firm’s 50 day moving average is $0.07 and its 200 day moving average is $0.08.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- Best Stocks Under $10.00
- The Average 401k Balance by Age Explained
- Financial Services Stocks Investing
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 3 Fintech Stocks With Good 2021 Prospects
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
